vs

Side-by-side financial comparison of CONSTELLIUM SE (CSTM) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $2.2B, roughly 2.0× CONSTELLIUM SE). Emerson Electric runs the higher net margin — 13.9% vs 5.1%, a 8.8% gap on every dollar of revenue. Emerson Electric produced more free cash flow last quarter ($602.0M vs $109.0M).

Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

CSTM vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
2.0× larger
EMR
$4.3B
$2.2B
CSTM
Higher net margin
EMR
EMR
8.8% more per $
EMR
13.9%
5.1%
CSTM
More free cash flow
EMR
EMR
$493.0M more FCF
EMR
$602.0M
$109.0M
CSTM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CSTM
CSTM
EMR
EMR
Revenue
$2.2B
$4.3B
Net Profit
$112.0M
$605.0M
Gross Margin
53.2%
Operating Margin
7.5%
17.8%
Net Margin
5.1%
13.9%
Revenue YoY
4.1%
Net Profit YoY
3.4%
EPS (diluted)
$0.79
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSTM
CSTM
EMR
EMR
Q4 25
$2.2B
$4.3B
Q3 25
$2.2B
$4.9B
Q2 25
$2.1B
$4.6B
Q1 25
$2.0B
$4.4B
Q4 24
$4.2B
Q3 24
$4.6B
Q2 24
$1.9B
$4.4B
Q1 24
$4.4B
Net Profit
CSTM
CSTM
EMR
EMR
Q4 25
$112.0M
$605.0M
Q3 25
$88.0M
$637.0M
Q2 25
$36.0M
$586.0M
Q1 25
$37.0M
$485.0M
Q4 24
$585.0M
Q3 24
$996.0M
Q2 24
$76.0M
$329.0M
Q1 24
$501.0M
Gross Margin
CSTM
CSTM
EMR
EMR
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
52.8%
Q1 24
52.2%
Operating Margin
CSTM
CSTM
EMR
EMR
Q4 25
7.5%
17.8%
Q3 25
5.8%
16.4%
Q2 25
2.7%
16.1%
Q1 25
3.1%
14.2%
Q4 24
18.6%
Q3 24
14.7%
Q2 24
5.4%
10.4%
Q1 24
16.2%
Net Margin
CSTM
CSTM
EMR
EMR
Q4 25
5.1%
13.9%
Q3 25
4.1%
13.1%
Q2 25
1.7%
12.9%
Q1 25
1.9%
10.9%
Q4 24
14.0%
Q3 24
21.6%
Q2 24
3.9%
7.5%
Q1 24
11.4%
EPS (diluted)
CSTM
CSTM
EMR
EMR
Q4 25
$0.79
$1.07
Q3 25
$0.62
$1.12
Q2 25
$0.25
$1.04
Q1 25
$0.26
$0.86
Q4 24
$1.02
Q3 24
$1.74
Q2 24
$0.51
$0.57
Q1 24
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSTM
CSTM
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$120.0M
Total DebtLower is stronger
$1.9B
$7.6B
Stockholders' EquityBook value
$952.0M
$20.3B
Total Assets
$5.4B
$41.9B
Debt / EquityLower = less leverage
2.00×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSTM
CSTM
EMR
EMR
Q4 25
$120.0M
Q3 25
$122.0M
Q2 25
$133.0M
Q1 25
$118.0M
Q4 24
Q3 24
Q2 24
Q1 24
Total Debt
CSTM
CSTM
EMR
EMR
Q4 25
$1.9B
$7.6B
Q3 25
$2.0B
$8.9B
Q2 25
$2.0B
$8.3B
Q1 25
$1.9B
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
CSTM
CSTM
EMR
EMR
Q4 25
$952.0M
$20.3B
Q3 25
$845.0M
$20.3B
Q2 25
$780.0M
$19.9B
Q1 25
$745.0M
$19.2B
Q4 24
$20.5B
Q3 24
$21.6B
Q2 24
$796.0M
$20.8B
Q1 24
$20.9B
Total Assets
CSTM
CSTM
EMR
EMR
Q4 25
$5.4B
$41.9B
Q3 25
$5.4B
$42.0B
Q2 25
$5.4B
$42.5B
Q1 25
$5.2B
$42.0B
Q4 24
$42.6B
Q3 24
$44.2B
Q2 24
$45.6B
Q1 24
$46.4B
Debt / Equity
CSTM
CSTM
EMR
EMR
Q4 25
2.00×
0.37×
Q3 25
2.34×
0.44×
Q2 25
2.53×
0.42×
Q1 25
2.56×
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSTM
CSTM
EMR
EMR
Operating Cash FlowLast quarter
$218.0M
$699.0M
Free Cash FlowOCF − Capex
$109.0M
$602.0M
FCF MarginFCF / Revenue
5.0%
13.9%
Capex IntensityCapex / Revenue
5.0%
2.2%
Cash ConversionOCF / Net Profit
1.95×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$159.0M
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSTM
CSTM
EMR
EMR
Q4 25
$218.0M
$699.0M
Q3 25
$99.0M
$3.1B
Q2 25
$114.0M
$1.1B
Q1 25
$58.0M
$241.0M
Q4 24
$777.0M
Q3 24
$3.3B
Q2 24
$138.0M
$1.1B
Q1 24
$743.0M
Free Cash Flow
CSTM
CSTM
EMR
EMR
Q4 25
$109.0M
$602.0M
Q3 25
$24.0M
$2.7B
Q2 25
$37.0M
$977.0M
Q1 25
$-11.0M
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
Q2 24
$54.0M
$998.0M
Q1 24
$661.0M
FCF Margin
CSTM
CSTM
EMR
EMR
Q4 25
5.0%
13.9%
Q3 25
1.1%
54.9%
Q2 25
1.8%
21.5%
Q1 25
-0.6%
3.5%
Q4 24
16.6%
Q3 24
63.1%
Q2 24
2.8%
22.8%
Q1 24
15.1%
Capex Intensity
CSTM
CSTM
EMR
EMR
Q4 25
5.0%
2.2%
Q3 25
3.5%
8.9%
Q2 25
3.7%
2.0%
Q1 25
3.5%
2.0%
Q4 24
2.0%
Q3 24
9.1%
Q2 24
4.3%
2.1%
Q1 24
1.9%
Cash Conversion
CSTM
CSTM
EMR
EMR
Q4 25
1.95×
1.16×
Q3 25
1.13×
4.86×
Q2 25
3.17×
1.83×
Q1 25
1.57×
0.50×
Q4 24
1.33×
Q3 24
3.35×
Q2 24
1.82×
3.31×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSTM
CSTM

Packaging Rolled Products$1.0B46%
Automotive Rolled Products$318.0M14%
Aerospace Rolled Products$270.0M12%
Transportation Industry Defense And Other Rolled Products$232.0M11%
Automotive Extruded Products$220.0M10%
Other Extruded Products$132.0M6%
Specialty And Other Thin Rolled Products$22.0M1%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons